 |
 |
 |
 
|
|
 |
||||
 |
||||
|
Galmed raised $1.25 Million August 13, 2008 GalMed raised $1.25 Million in convertible bonds. The company will use the proceeds to fund its Phase I trials of its lead compound Aramchol |
|
|
|
|
|
|
||||
|
||||
|
Galmed raised $1.25 Million August 13, 2008 GalMed raised $1.25 Million in convertible bonds. The company will use the proceeds to fund its Phase I trials of its lead compound Aramchol |
Back to Top